FDA Resumes Domestic Surveillance Inspections

Citing a decline in COVID-19 cases, the FDA resumed conducting domestic surveillance inspections across all commodities yesterday, February 7. The agency will also proceed with previously planned foreign surveillance inspections that have received country clearance and that are within CDC’s Level 1 or Level 2 COVID-19 travel recommendations; other foreign surveillance inspections will be rescheduled.... Continue Reading